# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Camurati Engelmann Disease

Camurati-Engelmann DiseaseDiaphyseal dysplasia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 24 results.
LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)
Status: Not yet recruiting
Last Changed: Jul 24, 2019
First Received: Jul 24, 2019
Disease(s): Colorectal Cancer Metastatic
Intervention(s): LY3200882
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer
Status: Recruiting
Last Changed: Nov 06, 2019
First Received: May 22, 2015
Disease(s): Prostate Cancer
Intervention(s): Enzalutamide, LY2157299
Locations: Sibley Memorial Hospital, Washington, District of Columbia, United States
Northwestern University, Chicago, Illinois, United States
University of Chicago, Chicago, Illinois, United States
Johns Hopkins University, Baltimore, Maryland, United States
The Role and Intervention of TGF-β in Abdominal Radiation Injury
Status: Not yet recruiting
Last Changed: Sep 25, 2018
First Received: Aug 03, 2018
Disease(s): Radiotherapy Side Effect, Taking Captopril
Intervention(s): Captopril 12.5 Mg
Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.
Status: Recruiting
Last Changed: May 08, 2020
First Received: Apr 26, 2019
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Epigallocatechin-3-gallate (EGCG)
Locations: UC San Francisco, San Francisco, California, United States
TGF-beta Trap (M7824) and NHS-IL12 (M9241) Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies
Status: Not yet recruiting
Last Changed: Jun 02, 2020
First Received: Jan 22, 2020
Disease(s): Urothelial Cancer, Bladder Cancer, Genitourinary Cancer, Urogenital Neoplasms, Urogenital Cancer
Intervention(s): M7824, M9241, Stereotactic body radiation therapy (SBRT)
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for p16-Negative Resectable Head and Neck Squamous Cell Carcinoma
Status: Recruiting
Last Changed: Jun 02, 2020
First Received: Jan 30, 2020
Disease(s): Head and Neck Cancer, Head and Neck Neoplasms
Intervention(s): M7824, N803, TriAd vaccine
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
The Effect of Oral Polymeric Diet Enriched With TGF-beta 2 (Modulen) on Clinical Response and Mucosal Healing in Adult Patients With Newly Diagnosed Crohn's Disease
Status: Not yet recruiting
Last Changed: Jan 18, 2020
First Received: Jan 18, 2020
Disease(s): Crohn Disease
Intervention(s): Modulen, Budesonide
Locations: Hillel Yaffe Medical Center, Hadera, Israel
Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects
Status: Recruiting
Last Changed: Jun 17, 2019
First Received: Dec 09, 2014
Disease(s): Hypertension
Locations: IRCCS Neuromed, Pozzilli, Isernia, Italy
Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas
Status: Not yet recruiting
Last Changed: May 29, 2020
First Received: May 29, 2020
Disease(s): Solid Tumor, Lymphoma
Intervention(s): SHR2554+SHR1701, SHR1701
Locations: Department of Biotherapeutic, Chinese PLA General Hospital, Beijing, China
TGF-(Beta) and Susceptibility to RSV
Status: Recruiting
Last Changed: May 21, 2020
First Received: Oct 20, 2010
Disease(s): Asthma
Locations: NIEHS Clinical Research Unit (CRU), Research Triangle Park, North Carolina, United States